Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (igf) binding protein-1: Evidence for an IGF-II autocrine growth loop

Jose A. Figueroa, Adrian V. Lee, James G. Jackson, Douglas Yee

Research output: Contribution to journalArticlepeer-review

73 Scopus citations

Abstract

In this study, we examined the expression of insulin-like growth factor (IGF) ligands, receptors, (IGFR1, IGFR2), and binding proteins (IGFBPs) in the human prostate cancer cell line DU145, as well as its mitogenic response to the IGFs. Using RNase protection assays, we found expression of IGF-II, IGFR1, and IGFR2 but failed to detect IGF-I messenger RNA. Distinct binding protein species as well as immunoreactive IGF-II were detected in conditioned media using radioligand and immunoblotting assays. Compared with controls, treatment with exogenous IGF-I and IGF-II resulted in stimulation of monolayer and anchorage-independent growth. Recombinant human IGFBP-1, which binds IGF-II with high affinity, inhibited IGF-II-induced monolayer growth and both baseline and IGF-II-induced anchorage-independent growth in this cell line. Our data suggest IGF-II is as an autocrine growth factor in DU145 cells, and that inhibition of IGF-II-dependent growth of human prostate cancer cells may represent a new therapeutic strategy for this disease.

Original languageEnglish (US)
Pages (from-to)3476-3482
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume80
Issue number12
DOIs
StatePublished - Dec 1995

Fingerprint

Dive into the research topics of 'Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (igf) binding protein-1: Evidence for an IGF-II autocrine growth loop'. Together they form a unique fingerprint.

Cite this